ELUTIA INC. - CLASS A COMMON STOCK

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

22 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

21 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Elutia Confirms No Material Impact from Global Tariffs

14 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

EluPro™ Named as 2025 Edison Award Winner

04 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Elutia to Participate in Upcoming Investor Conferences

03 Apr 2025 08:00:35 By Nasdaq GlobeNewswire

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

02 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

27 Mar 2025 16:05:23 By Nasdaq GlobeNewswire

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

25 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

06 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

20 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

Elutia Announces $15.0 Million Registered Direct Offering

03 Feb 2025 06:30:00 By Nasdaq GlobeNewswire

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

14 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

06 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

02 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

14 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

13 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

29 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

23 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

18 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Elutia Celebrates First Year

06 Sep 2024 16:23:52 By Nasdaq GlobeNewswire